Immuno-Oncology (IO) Market Size, Share, Growth, Analysis and Forecast to 2030
Immuno-Oncology (IO) Market Overview:
The global immuno-oncology
market is projected to grow at a robust CAGR of approximately
21% over the next five years. This strong expansion is fueled by the rising
global cancer burden, continuous breakthroughs in immunotherapy and precision
medicine, supportive regulatory frameworks, increasing investments in cancer
immunotherapy research and development, and the broadening use of
immuno-oncology treatments beyond conventional cancer indications.
Download Sample PDF Copy: https://meditechinsights.com/immuno-oncology-market/request-sample/
Report Overview
Immuno-oncology represents one of the most transformative
advances in modern cancer therapy, leveraging the body’s immune system to
detect and destroy malignant cells. In contrast to traditional treatment
modalities such as chemotherapy and radiation, which act directly on tumors,
immuno-oncology therapies work by stimulating or restoring immune system
function. Major therapeutic approaches include immune checkpoint inhibitors
such as PD-1 and PD-L1 inhibitors, chimeric antigen receptor T-cell (CAR-T)
therapies, bispecific antibodies, and therapeutic cancer vaccines. These
innovations have significantly reshaped cancer treatment by delivering
longer-lasting responses and improved survival across multiple cancer types.
Current research efforts are centered on improving treatment effectiveness,
addressing resistance mechanisms, and extending the applicability of
immuno-oncology through combination regimens and personalized treatment
strategies.
Rising Cancer Incidence to Drive
Market Growth
The increasing incidence and prevalence of cancer
worldwide remain key drivers of demand for immuno-oncology therapies. As cancer
continues to rank among the leading causes of mortality globally, the need for
more effective and durable treatment options is intensifying. According to the
World Health Organization, approximately 20 million new cancer cases and 9.7
million cancer-related deaths were reported in 2022. Cancer incidence is
expected to rise sharply due to aging populations, changing lifestyles, and
environmental exposures, with projections estimating more than 35 million new
cases by 2050—representing a 77% increase from 2022 levels. The growing burden
of lung, colorectal, breast, and prostate cancers has accelerated the adoption
of innovative therapies such as immune checkpoint inhibitors, CAR-T cell therapies,
and cancer vaccines. Additionally, lifestyle-related risk factors including
smoking, physical inactivity, and obesity further contribute to higher cancer
rates, reinforcing the need for advanced immuno-oncology solutions.
Consequently, pharmaceutical and biotechnology companies are significantly
increasing investments in research to develop next-generation therapies that
enhance clinical outcomes and extend patient survival.
Download Sample PDF Copy: https://meditechinsights.com/immuno-oncology-market/request-sample/
Advancements in Immuno-Oncology
Therapies: Emerging Innovations and Opportunities
The immuno-oncology landscape is evolving rapidly,
supported by recent regulatory approvals of bispecific T-cell engagers (BiTEs)
and renewed momentum in cancer vaccine development, particularly mRNA-based
platforms. Cell-based therapies, including CAR-T treatments, are expanding into
additional cancer indications and earlier stages of therapy, such as
non-Hodgkin’s lymphoma. Bispecific antibodies are gaining attention for their
ability to redirect T cells while simultaneously modulating immune checkpoints,
offering potential solutions to overcome immune exhaustion. Moreover, next-generation
immune checkpoint inhibitors that target multiple pathways may provide improved
efficacy compared to conventional combination therapies. Advances in targeting
and reshaping the tumor microenvironment to address resistance mechanisms are
creating substantial growth opportunities and driving innovation across the
immuno-oncology market.
Competitive Landscape
The global immuno-oncology market features a
competitive mix of well-established pharmaceutical companies and emerging
biotechnology firms. Key players include Bristol-Myers Squibb Company, Novartis
AG, F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., AstraZeneca, Sanofi,
Moderna, Inc., GSK plc, AbbVie Inc., and Merck & Co., Inc., among others.
Market participants are actively pursuing strategies such as novel product
development, strategic alliances and collaborations, and expansion into new
geographic regions to strengthen their market position and accelerate
innovation.
Browse Report: https://meditechinsights.com/immuno-oncology-market/
Market Segmentation
This report by Medi-Tech Insights provides the size
of the global immuno-oncology market at the regional- and country-level
from 2023 to 2030. The report further segments the market based on therapy
type, cancer type, end user.
·
Market Size & Forecast
(2023-2030), By Therapy Type, USD Million
o Immune Checkpoint Inhibitors (ICIs)
o CAR-T Cell Therapy
o Cancer Vaccines
o Bispecific Antibodies
o Monoclonal Antibodies
o Oncolytic Viruses
o Cytokine Therapy
o Others
·
Market Size & Forecast
(2023-2030), By Cancer Type, USD Million
o Lung Cancer
o Breast Cancer
o Colorectal Cancer
o Prostate Cancer
o Melanoma
o Ovarian Cancer
o Others
·
Market Size & Forecast
(2023-2030), By End User, USD Million
o Hospitals & Cancer Treatment Centers
o Specialty Clinics
o Others
·
Market Size & Forecast
(2023-2030), By Region, USD Million
o North America
§ US
§ Canada
o Europe
§ UK
§ Germany
§ France
§ Italy
§ Spain
§ Rest of Europe
o Asia Pacific
§ China
§ India
§ Japan
§ Rest of Asia Pacific
o Latin America
o Middle East & Africa
Related Report:
Proteomics Market - https://www.pharmiweb.com/press-release/2026-02-03/proteomics-market-2029-size-share-growth-analysis-and-research-report-to-forecast
Pharmacy Automation Market - https://www.pharmiweb.com/press-release/2026-02-03/pharmacy-automation-market-report-with-statistics-growth-opportunities-sales-trends-service-applications-and-forecast-2029
High Flow Oxygen Therapy Market - https://www.pharmiweb.com/press-release/2026-02-03/high-flow-oxygen-therapy-market-2026-revenue-advancement-strategy-and-geographical-performance-forecast-to-2029
Biometrics as a Service (BaaS) in Healthcare Market - https://www.pharmiweb.com/press-release/2026-02-03/biometrics-as-a-service-baas-in-healthcare-market-to-witness-a-leap-by-leaching-cagr-of-approximately-20-by-the-end-of-2029
Computed Tomography Market - https://www.pharmiweb.com/press-release/2026-02-03/computed-tomography-market-size-share-future-growth-top-key-players-and-forecast-till-2029
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment